Schedule 13G ownership disclosure

COGENT BIOSCIENCES INC

Common Stock, $0.001 par value per share · CUSIP: 19240Q201

Event date: 2024-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners II, L.P.

    Shares: 6,446,917.00 · Class: 5.8%

  • VHCP Co-Investment Holdings II, LLC

    Shares: 6,446,917.00 · Class: 5.8%

  • VHCP Management II, LLC

    Shares: 6,446,917.00 · Class: 5.8%

  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 6,446,917.00 · Class: 5.8%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 6,446,917.00 · Class: 5.8%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 6,446,917.00 · Class: 5.8%

  • VHCP Management III, LLC

    Shares: 6,446,917.00 · Class: 5.8%

  • VHCP Management EG, LLC

    Shares: 6,446,917.00 · Class: 5.8%

  • Nimish Shah

    Shares: 6,446,917.00 · Class: 5.8%

  • Bong Y Koh

    Shares: 6,446,917.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-010591
Form type
SCHEDULE 13G/A
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Apr 11, 2025
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub